CN1879721A - A compound capsule for treating Bi syndrome - Google Patents
A compound capsule for treating Bi syndrome Download PDFInfo
- Publication number
- CN1879721A CN1879721A CNA2006100440755A CN200610044075A CN1879721A CN 1879721 A CN1879721 A CN 1879721A CN A2006100440755 A CNA2006100440755 A CN A2006100440755A CN 200610044075 A CN200610044075 A CN 200610044075A CN 1879721 A CN1879721 A CN 1879721A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- capsule
- radix aconiti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is a Chinese compound capsule for treating rheumatism prepared from the following raw materials (by weight ratio): seed of nuxvomica 100-180g, centipede 40-60g, processed radix aconiti 10-30g, processed radix aconiti kusnezoffii 10-30g, pawpaw 10-30g, Chinese angelica root each 12-36g, root of achyranthes 10-30g, dipsacus root 10-30g, diclofenac sodium 2-3g and piroxicam 0.8-1.2g.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of arthromyodynia, specifically relate to a kind of with in, Western medicine is in conjunction with the medicament capsule of treatment arthromyodynia of preparation.
Background technology
Arthromyodynia is the Chinese medicine noun, and it mainly comprises the multiple muscle of modern medicine indication rheumatic, rheumatoid arthritis and the antalgesic in joint.These diseases belong to commonly encountered diseases, frequently-occurring disease (have data be presented at China can account for the outpatient 10%), delay is difficult, meets inducement and is easy to recurrence, has a strong impact on people's work and life.Though along with medical science applied continuous development, have many relevant new drugs to come out, doctor trained in Western medicine does not have specific medicament so far yet, and rheumatism pain relieving class drug side effect is more, especially easily causes symptom of digestive tract yet, the part drug price is expensive partially, and patient can't bear the heavy load.The traditional Chinese medical science is in expelling wind and cold, eliminating dampness and dredging channels, and in addition blood-activating and qi-promoting is transferred the human righteousness, often can obtain better therapeutic effect, but mostly exist the course of treatment long, slow defective takes effect.
Summary of the invention
Purpose of the present invention is exactly at above-mentioned the deficiencies in the prior art, and a kind of compound medicine capsule is provided, can more effective, more promptly treat the various diseases that belong to rheumatic Bi syndrome such as rheumatic, rheumatoid arthritis.
For achieving the above object, raw material composition and the weight proportion thereof of making effective ingredient of the present invention are: Semen Strychni 100-180 gram, Scolopendra 40-60 gram, Radix Aconiti Preparata 10-30 gram, Radix Aconiti Kusnezoffii Preparata 10-30 gram, Fructus Chaenomelis 10-30 gram, Radix Angelicae Sinensis 12-36 gram, Radix Achyranthis Bidentatae 10-30 gram, Radix Dipsaci 10-30 gram, diclofenac 2-3 gram, piroxicam 0.8-1.2 gram.
The preferred prescription of medicine of the present invention is that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Semen Strychni 150 grams, Scolopendra 50 grams, Radix Aconiti Preparata 20 grams, Radix Aconiti Kusnezoffii Preparata 20 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 23 grams, Radix Achyranthis Bidentatae 20 grams, Radix Dipsaci 20 grams, diclofenac 2.5 grams, piroxicam 1 gram.
The preparation method of compound capsule that the present invention treats arthromyodynia is as follows:
1, Semen Strychni is put in the iron pan, it is an amount of to add water, and slow fire boils, and takes out after 8 hours, peels off crust, be cut into thick 0.5-1mm thin slice, airing is fried to being uniform sepia, pulverization, cross the 100-200 mesh sieve, then medicamental pulverata is incapsulated, every capsule powder charge 0.46 gram, this is the I capsule;
2, with in other 9 flavor, western drug mixes, pulverization is crossed the 100-200 mesh sieve, fully incapsulates behind the mix homogeneously, every capsule powder charge 0.5 gram, this is the II capsule.
Consumption and usage: the I capsule is taken once every night, and each 1-3 grain begins to take, gradually dosage in a small amount; The II capsule is taken once every night, each 4, takes simultaneously with the I capsule.
The present invention treats the compound capsule of arthromyodynia with the mutual compatibility of Chinese and western drugs, each most its length, play the effect of expelling cold and dampness, removing obstruction in the collateral to relieve pain altogether, be used for the treatment of various arthromyodynias such as rheumatic rheumatoid arthritis, rheumatic myalgia, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, sciatica, prove this medicine good effect through clinical trial for many years, instant effect, relapse rate is low, and drug safety is convenient, and medical expense is low.
Clinical observation on the therapeutic effect:
Select patient with rheumatoid arthritis 60 examples, be divided into two groups of treatment group and matched groups at random, every group 30 example.The treatment group is used so that compound capsule of the present invention is conventional: the II capsule is taken 4 every night, and from 1 beginning clothes every night, take the circumstances into consideration increases the I capsule earlier, keeps application after waiting to reach maintenance dose.Matched group is taken Tripterygium glycosides, and 60mg divided and took for 3 times every day, and Qin Pu gives birth to 0.8-1.0g, divides and takes for 2 times.All in 1 month post-evaluation curative effect of treatment.Two groups of cases are all learned by statistics aspect age, sex, the state of an illness and are handled P＞0.05, no significant difference.Selected case is the case of the stable disease of making a definite diagnosis by clinical diagnosis of rheumatoid arthritis standard, and does not all use hormone medicine.
Criterion of therapeutical effect: produce effects: symptom and sign is obviously alleviated, and swollen joint obviously disappears, and pain is controlled substantially; Effectively: symptom and sign is partly alleviated, and swollen joint disappears to some extent, and pain alleviates to some extent; Invalid: symptom and sign improves with the preceding nothing of treatment.Therapeutic effect such as following table:
Table 1 treatment group and matched group curative effect are relatively
| Group | The example number | Produce effects | Effectively | Invalid |
| Treatment group matched group | 30 30 | 26 22 | 3 6 | 1 2 |
Two groups contrast as can be seen, treatment group obvious effective rate 87%, and matched group obvious effective rate 73%, thereby compound capsule of the present invention has positive effect for the treatment rheumatoid arthritis.
The specific embodiment
Embodiment one
Raw material composition and the weight proportion thereof of making compound capsule effective ingredient of the present invention are: Semen Strychni 100 grams, Scolopendra 60 grams, Radix Aconiti Preparata 10 grams, Radix Aconiti Kusnezoffii Preparata 30 grams, Fructus Chaenomelis 10 grams, Radix Angelicae Sinensis 36 grams, Radix Achyranthis Bidentatae 10 grams, Radix Dipsaci 30 grams, diclofenac 2 grams, piroxicam 0.8 gram.
Embodiment two
Raw material composition and the weight proportion thereof of making compound capsule effective ingredient of the present invention are: Semen Strychni 180 grams, Scolopendra 40 grams, Radix Aconiti Preparata 30 grams, Radix Aconiti Kusnezoffii Preparata 10 grams, Fructus Chaenomelis 30 grams, Radix Angelicae Sinensis 12 grams, Radix Achyranthis Bidentatae 30 grams, Radix Dipsaci 10 grams, diclofenac 3 grams, piroxicam 1.2 grams.
Embodiment three
Raw material composition and the weight proportion thereof of making compound capsule effective ingredient of the present invention are: Semen Strychni 150 grams, Scolopendra 50 grams, Radix Aconiti Preparata 20 grams, Radix Aconiti Kusnezoffii Preparata 20 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 23 grams, Radix Achyranthis Bidentatae 20 grams, Radix Dipsaci 20 grams, diclofenac 2.5 grams, piroxicam 1 gram.
Embodiment three is a most preferred embodiment.The preparation method of each embodiment as previously described.
Claims (2)
1, a kind of compound capsule for the treatment of arthromyodynia, it is characterized in that raw material composition and the weight proportion thereof of making this effective ingredient are: Semen Strychni 100-180 gram, Scolopendra 40-60 gram, Radix Aconiti Preparata 10-30 gram, Radix Aconiti Kusnezoffii Preparata 10-30 gram, Fructus Chaenomelis 10-30 gram, Radix Angelicae Sinensis 12-36 gram, Radix Achyranthis Bidentatae 10-30 gram, Radix Dipsaci 10-30 gram, diclofenac 2-3 gram, piroxicam 0.8-1.2 gram.
2, the compound capsule of treatment arthromyodynia according to claim 1, it is characterized in that raw material composition and the weight proportion thereof of making this effective ingredient are: Semen Strychni 150 grams, Scolopendra 50 grams, Radix Aconiti Preparata 20 grams, Radix Aconiti Kusnezoffii Preparata 20 grams, Fructus Chaenomelis 20 grams, Radix Angelicae Sinensis 23 grams, Radix Achyranthis Bidentatae 20 grams, Radix Dipsaci 20 grams, diclofenac 2.5 grams, piroxicam 1 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100440755A CN100411650C (en) | 2006-05-09 | 2006-05-09 | A compound capsule for treating Bi syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100440755A CN100411650C (en) | 2006-05-09 | 2006-05-09 | A compound capsule for treating Bi syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1879721A true CN1879721A (en) | 2006-12-20 |
| CN100411650C CN100411650C (en) | 2008-08-20 |
Family
ID=37518222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100440755A Expired - Fee Related CN100411650C (en) | 2006-05-09 | 2006-05-09 | A compound capsule for treating Bi syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411650C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103127300A (en) * | 2013-03-08 | 2013-06-05 | 崔合芳 | Chinese medicinal composition for fumigation treatment of lumbar disc herniation |
| CN105497441A (en) * | 2015-12-30 | 2016-04-20 | 杨发祥 | Plaster for treating arthralgia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072500C (en) * | 1998-09-08 | 2001-10-10 | 田雪云 | Medical capsules for treating arthritides and its preparing process |
| CN1197603C (en) * | 2003-04-04 | 2005-04-20 | 康随利 | Pill for relaxing muscles and activating collateral flow |
-
2006
- 2006-05-09 CN CNB2006100440755A patent/CN100411650C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103127300A (en) * | 2013-03-08 | 2013-06-05 | 崔合芳 | Chinese medicinal composition for fumigation treatment of lumbar disc herniation |
| CN103127300B (en) * | 2013-03-08 | 2014-03-19 | 崔合芳 | Chinese medicinal composition for fumigation treatment of lumbar disc herniation |
| CN105497441A (en) * | 2015-12-30 | 2016-04-20 | 杨发祥 | Plaster for treating arthralgia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100411650C (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100411650C (en) | A compound capsule for treating Bi syndrome | |
| CN103948782A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition | |
| CN101474271B (en) | Medicament for treating uarthritis | |
| CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
| CN104000863A (en) | Medicinal composition for treating malignant tumor accompanied with gall-stone and preparation method and medical application thereof | |
| CN102824414A (en) | Medicinal tea used for treating constipation | |
| CN102846750B (en) | Fengtongning composite preparation and preparation method thereof | |
| CN105832732A (en) | Pharmaceutical composition for treatment of gastric cancer and application of pharmaceutical composition for treatment of gastric cancer | |
| CN1141966C (en) | Stone expelling medicine powder | |
| CN106038566B (en) | A kind of pharmaceutical composition and its application for curing gastric cancer | |
| CN100427132C (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN100509003C (en) | Medicament of treating psoriasis | |
| CN113244363B (en) | Traditional Chinese medicine cake moxibustion for orthopedics department as well as preparation method and application thereof | |
| CN106266152A (en) | A kind of pharmaceutical composition treating eczema and its production and use | |
| CN103536745A (en) | Traditional Chinese medicinal watered pills for treating hyperplasia of mammary glands | |
| CN101618118B (en) | Application of Chinese medicinal composition in preparing medicament for treating cystitis | |
| CN101194994B (en) | Externally used medicament for treating toothache | |
| CN103989769B (en) | A kind of pharmaceutical composition for health slimming | |
| CN106389439A (en) | Chinese and western medicine composition for curing liver cirrhosis ascites, and preparation method and application thereof | |
| CN106902295B (en) | Toxicity-reducing and efficacy-enhancing traditional Chinese medicine tablet for treating gout with syndrome of wind-damp-heat | |
| CN1305517C (en) | Mastoproliferation treating medicine | |
| CN103638457B (en) | Human immunity repair composition and preparation method | |
| CN1167439C (en) | Anticancer Chinese herbal medicine and its prepn | |
| CN107670011A (en) | A kind of chinese-western medicine preparation of reducing blood lipid and preparation method thereof | |
| CN100563679C (en) | The medicine of treatment hepatitis B great three positive, small three positive hepatopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 |